Definitive Contract HHSD200201691934C
Award Date
9/20/16
Potential Completion Date
9/14/17
Potential Value
$521K
Federal Agency
CDC Pittsburgh
Awardee
Rhode Island Hospital
Ultimate Awardee
The Miriam Hospital
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $547,646 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Microbiome Health Research Institute Inc. (doing business as Openbiome), a non-profit organization. The contract is for the R.A.C.E. program, which involves the recruitment and enrollment of 180 patients, treatment of 20 patients including sample collection and follow up for a clinical trial. Microbiome Health Research Institute Inc. has subcontracted a portion of the work...
This is a $497,911.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Microbiome Health Research Institute Inc. (doing business as Openbiome), a non-profit organization. The contract is for a VRE Decolonization Study, which involves the recruitment and treatment of 23 patients, as well as sample collection, to be performed by a subcontractor, Trustees of Indiana University (Indiana University). The contract does not have a set-aside designation. As a...
This federal contract award, HHSD200201691773I|75D30121F00002, was issued by the Centers for Disease Control and Prevention (CDC) to Brown University. The $6,087,547.39 delivery order contract is part of the larger Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite delivery vehicle. The contract, which does not have a set-aside designation, aims to conduct research for the SHEPHERD 2021 DOMAIN 3-C001 project. Key subcontractors include Rhode Island...
This is a $459,721 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Yale University, a private research university, to conduct research on "Microbiome Disruption Indices." The contract has no set-aside designation. As a subcontractor, the University of Maryland, Baltimore (UMB) is providing frozen patient samples and clinical data to support the research effort. This contract award is part of Yale University's broader portfolio of federal prime...
This is a $2,572,069.63 firm fixed-price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Brown University, a private Ivy League research university located in Providence, Rhode Island. The order is part of the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite delivery contract, which allows the CDC to issue task orders for research and technical services. This particular delivery order is for "other...
<p>This is a $546,085 firm fixed-price definitive contract awarded on September 1, 2020 by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Yale University, a private university, for the identification of epidemiologic and microbiome-related risk factors. The contract has an ultimate completion date of February 28, 2022. This contract does not have a set-aside designation. The place of performance is Hamden, CT.</p>
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Virginia Commonwealth University (VCU) for the project "MICROBIOME DISRUPTION INDICES". The contract has a Firm Fixed Price structure and a ceiling value of $322,304.00. The period of performance ends on September 29, 2019. This award does not have a set-aside designation. VCU is a public research university that provides a wide range of services to the federal government, including...
This is a $283,965 firm fixed-price definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Northwestern University's Sponsored Research division. The contract, which does not have a set-aside designation, was awarded on September 30, 2018 and has a completion date of September 29, 2019. The contracted work involves research to address three key questions regarding the microbiomes of healthcare facility surfaces: 1) what...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $12,406 Firm Fixed Price purchase order contract to the Rhode Island Department of Health (RIDOH) for the RHODE ISLAND NDI 2023 project. This contract is not set aside for any specific business type. The contract has an ultimate completion date of May 1, 2024. RIDOH, a U.S. state government entity, is the prime contractor and will perform the work in Durham, North Carolina. Based on RIDOH's history, the contract likely...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $387,955.00 firm fixed price contract to the Board of Regents of the University of Nebraska for in vitro and in vivo human microbiome models research. No set-aside was used for this award. The University of Nebraska is serving as the prime contractor, with Baylor College of Medicine as a subcontractor to perform work related to using complementary in vitro and in vivo models of the human microbiome...